In this study, we demonstrated that the inhibition of p38 MAPK not only mitigated the aggravating effects of O3 on pulmonary inflammation and AHR, but also restored partly the O3-impaired inhibitory effects of dexamethasone. This evidence concerns the gene AHR and inflammatory response.